Bio-Path Holdings Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year Ending	TTM	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	2018 - 2004
Net Income	-13.96	-16.08	-13.87	-10.44	-10.88	-8.6	Upgrade
Depreciation & Amortization	0.18	0.18	0.18	0.16	0.15	0.23	Upgrade
Share-Based Compensation	0.7	0.73	0.85	0.82	0.58	0.68	Upgrade
Other Operating Activities	4.16	3.63	-2.26	-0.46	-0.81	-0.68	Upgrade
Operating Cash Flow	-8.92	-11.54	-15.1	-9.92	-10.96	-8.36	Upgrade
Capital Expenditures	0	0	-0.02	-0.07	0	0	Upgrade
Investing Cash Flow	0	0	-0.02	-0.07	0	0	Upgrade
Share Issuance / Repurchase	0.69	2.2	1.73	20.01	4.29	27.78	Upgrade
Financing Cash Flow	0.69	2.2	1.73	20.01	4.29	27.78	Upgrade
Net Cash Flow	-6.54	-9.33	-13.39	10.02	-6.67	19.42	Upgrade
Free Cash Flow	-8.92	-11.54	-15.12	-9.99	-10.96	-8.36	Upgrade
Free Cash Flow Per Share	-13.79	-24.13	-41.55	-29.70	-56.98	-62.94	Upgrade

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).